An official website of the United States government
Magnetic particle imaging (MPI) is a novel biomedical imaging modality that allows non-invasive, tomographic, and quantitative tracking of the distribution of superparamagnetic iron oxide nanoparticle (SPION) tracers. While MPI possesses high sensitivity, detecting nanograms of iron, it does not provide anatomical information. Computed tomography (CT) is a widely used biomedical imaging modality that yields anatomical information at high resolution. A multimodal imaging agent combining the benefits of MPI and CT imaging would be of interest. Here we combine MPI-tailored SPIONs with CT-contrast hafnium oxide (hafnia) nanoparticles using flash nanoprecipitation to obtain dual-imaging MPI/CT agents. Co-encapsulation of iron oxide and hafnia in the composite nanoparticles was confirmed via transmission electron microscopy and elemental mapping. Equilibrium and dynamic magnetic characterization show a reduction in effective magnetic diameter and changes in dynamic magnetic susceptibility spectra at high oscillating field frequencies, suggesting magnetic interactions within the composite dual imaging tracers. The MPI performance of the dual imaging agent was evaluated and compared to the commercial tracer ferucarbotran. The dual-imaging agent has MPI sensitivity that is ∼3× better than this commercial tracer. However, worsening of MPI resolution was observed in the composite tracer when compared to individually coated SPIONs. This worsening resolution could result from magnetic dipolar interactions within the composite dual imaging tracer. The CT performance of the dual imaging agent was evaluated in a pre-clinical animal scanner and a clinical scanner, revealing better contrast compared to a commercial iodine-based contrast agent. We demonstrate that the dual imaging agent can be differentiated from the commercial iodine contrast agent using dual energy CT (DECT) imaging. Furthermore, the dual imaging agent displayed energy-dependent CT contrast arising from the combination of SPION and hafnia, making it potentially suitable for virtual monochromatic imaging of the contrast agent distribution using DECT.
more »
« less
This content will become publicly available on January 28, 2026
Effect of tracer size distribution on magnetic particle imaging performance
Abstract Magnetic particle imaging (MPI) is a tracer-based tomographic imaging technique utilized in applications such as lung perfusion imaging, cancer diagnosis, stem cell tracking, etc. The goal of translating MPI to clinical use has prompted studies on further improving the spatial-temporal resolutions of MPI through various methods, including image reconstruction algorithm, scanning trajectory design, magnetic field profile design, and tracer design. Iron oxide magnetic nanoparticles (MNPs) are favored for MPI and magnetic resonance imaging (MRI) over other materials due to their high biocompatibility, low cost, and ease of preparation and surface modification. For core–shell MNPs, the tracers’ magnetic core size and non-magnetic coating layer characteristics can significantly affect MPI signals through dynamic magnetization relaxations. Most works to date have assumed an ensemble of MNP tracers with identical sizes, ignoring that artificially synthesized MNPs typically follow a log-normal size distribution, which can deviate theoretical results from experimental data. In this work, we first characterize the size distributions of four commercially available iron oxide MNP products and then model the collective magnetic responses of these MNPs for MPI applications. For an ensemble of MNP tracers with size standard deviations ofσ, we applied a stochastic Langevin model to study the effect of size distribution on MPI imaging performance. Under an alternating magnetic field (AMF), i.e., the excitation field in MPI, we collected the time domain dynamic magnetizations (M-t curves), magnetization-field hysteresis loops (M-H curves), point-spread functions (PSFs), and higher harmonics from these MNP tracers. The intrinsic MPI spatial resolution, which is related to the full width at half maximum (FWHM) of the PSF profile, along with the higher harmonics, serve as metrics to provide insights into how the size distribution of MNP tracers affects MPI performance.
more »
« less
- Award ID(s):
- 2011401
- PAR ID:
- 10590025
- Publisher / Repository:
- Phys. Scr.
- Date Published:
- Journal Name:
- Physica Scripta
- Volume:
- 100
- Issue:
- 2
- ISSN:
- 0031-8949
- Page Range / eLocation ID:
- 025529
- Format(s):
- Medium: X
- Sponsoring Org:
- National Science Foundation
More Like this
-
-
Magnetic nanoparticles (MNPs), especially iron oxide (Fe3O4), display distinctive superparamagnetic characteristics and elevated surface-area-to-volume ratios, facilitating improved physicochemical interactions with solutes and pollutants. These characteristics make MNPs strong contenders for use in water treatment applications. This research investigates the application of iron oxide MNPs synthesized via co-precipitation as innovative draw solutes in forward osmosis (FO) for treating synthetic produced water (SPW). The FO membrane underwent surface modification with sulfobetaine methacrylate (SBMA), a zwitterionic polymer, to increase hydrophilicity, minimize fouling, and elevate water flux. The SBMA functional groups aid in electrostatic repulsion of organic and inorganic contaminants, simultaneously encouraging robust hydration layers that improve water permeability. This adjustment is vital for sustaining consistent flux performance while functioning with MNP-based draw solutions. Material analysis through thermogravimetric analysis (TGA), scanning electron microscopy (SEM), and Fourier-transform infrared spectroscopy (FTIR) verified the MNPs’ thermal stability, consistent morphology, and modified surface chemistry. The FO experiments showed a distinct relationship between MNP concentration and osmotic efficiency. At an MNP dosage of 10 g/L, the peak real-time flux was observed at around 3.5–4.0 L/m2·h. After magnetic regeneration, 7.8 g of retrieved MNPs generated a steady flow of ~2.8 L/m2·h, whereas a subsequent regeneration (4.06 g) resulted in ~1.5 L/m2·h, demonstrating partial preservation of osmotic driving capability. Post-FO draw solutions, after filtration, exhibited total dissolved solids (TDS) measurements that varied from 2.5 mg/L (0 g/L MNP) to 227.1 mg/L (10 g/L MNP), further validating the effective dispersion and solute contribution of MNPs. The TDS of regenerated MNP solutions stayed similar to that of their fresh versions, indicating minimal loss of solute activity during the recycling process. The combined synergistic application of SBMA-modified FO membranes and regenerable MNP draw solutes showcases an effective and sustainable method for treating produced water, providing excellent water recovery, consistent operational stability, and opportunities for cyclic reuse.more » « less
-
Abstract Rapid and accurate assessment of conditions characterized by altered blood flow, cardiac blood pooling, or internal bleeding is crucial for diagnosing and treating various clinical conditions. While widely used imaging modalities such as magnetic resonance imaging (MRI), computed tomography (CT), and ultrasound offer unique diagnostic advantages, they fall short for specific indications due to limited penetration depth and prolonged acquisition times. Magnetic particle imaging (MPI), an emerging tracer‐based technique, holds promise for blood circulation assessments, potentially overcoming existing limitations with reduction in background signals and high temporal and spatial resolution, below the millimeter scale. Successful imaging of blood pooling and impaired flow necessitates tracers with diverse circulation half‐lives optimized for MPI signal generation. Recent MPI tracers show potential in imaging cardiovascular complications, vascular perforations, ischemia, and stroke. The impressive temporal resolution and penetration depth also position MPI as an excellent modality for real‐time vessel perfusion imaging via functional MPI (fMPI). This review summarizes advancements in optimized MPI tracers for imaging blood circulation and analyzes the current state of pre‐clinical applications. This work discusses perspectives on standardization required to transition MPI from a research endeavor to clinical implementation and explore additional clinical indications that may benefit from the unique capabilities of MPI.more » « less
-
Magnetic nanoparticles (MNPs) are highly versatile nanomaterials in nanomedicine, owing to their diverse magnetic properties, which can be tailored through variations in size, shape, composition, and exposure to inductive magnetic fields. Over four decades of research have led to the clinical approval or ongoing trials of several MNP formulations, fueling continued innovation. Beyond traditional applications in drug delivery, imaging, and cancer hyperthermia, MNPs have increasingly advanced into molecular medicine. Under external magnetic fields, MNPs can generate mechano- or thermal stimuli to modulate individual molecules or cells deep within tissue, offering precise, remote control of biological processes at cellular and molecular levels. These unique capabilities have opened new avenues in emerging fields such as genome editing, cell therapies, and neuroscience, underpinned by a growing understanding of nanomagnetism and the molecular mechanisms responding to mechanical and thermal cues. Research on MNPs as a versatile synthetic material capable of engineering control at the cellular and molecular levels holds great promise for advancing the frontiers of molecular medicine, including areas such as genome editing and synthetic biology. This review summarizes recent clinical studies showcasing the classical applications of MNPs and explores their integration into molecular medicine, with the goal of inspiring the development of next-generation MNP-based platforms for disease treatment.more » « less
-
Magnetic particle imaging (MPI) is an emerging noninvasive molecular imaging modality with high sensitivity and specificity, exceptional linear quantitative ability, and potential for successful applications in clinical settings. Computed tomography (CT) is typically combined with the MPI image to obtain more anatomical information. Herein, a deep learning‐based approach for MPI‐CT image segmentation is presented. The dataset utilized in training the proposed deep learning model is obtained from a transgenic mouse model of breast cancer following administration of indocyanine green (ICG)‐conjugated superparamagnetic iron oxide nanoworms (NWs‐ICG) as the tracer. The NWs‐ICG particles progressively accumulate in tumors due to the enhanced permeability and retention (EPR) effect. The proposed deep learning model exploits the advantages of the multihead attention mechanism and the U‐Net model to perform segmentation on the MPI‐CT images, showing superb results. In addition, the model is characterized with a different number of attention heads to explore the optimal number for our custom MPI‐CT dataset.more » « less
